Clinical Trials Browser

Phase 2 × Recurrent Lung Squamous Cell Carcinoma × sapanisertib × Clear all

NCT02417701 2022-04-05

Sapanisertib in Treating Patients With Stage IV or Recurrent Lung Cancer

Phase 2 Completed

34 enrolled 10 charts

Recurrent Lung Squamous Cell Carcinoma